Shilpa Medicare Limited is the first company to receive approval for Manufacturing & Market of Pemetrexed Injection 10 ml, 50 ml, 85 ml, and 100 ml in India
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Aurobindo will respond to the US FDA within the stipulated timelines
Luforbec® 100/6 pMDI aims to provide comprehensive support to patients and healthcare professionals
Shivalik Rasayan Limited has issued LOA to Medicamen Biotech to use its DMF grade Bortezomib API for formulation of Bortezomib injection 3.5mg/ vial
The collaboration between CARER and Wholeleaf aims to offer an integrated approach to cancer patients, combining services and products to optimize their well-being
USFDA concludes inspection at Zydus' formulation manufacturing facility at SEZ 2, Ahmedabad
The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22
Subscribe To Our Newsletter & Stay Updated
